Journal Articles — Michele K. York, Ph.D., ABPP-CN

Dr. Michele K. York has co-authored 82 journal articles. They are listed here in reverse chronological order and grouped by published year. Click on the Expand plus symbol or Collapse minus symbol symbol to expand/collapse the list of journal publications by year, respectively.

Click on the PubMed link for details of that publication.

The cite count designates the number of times the publication has been cited by other papers indexed in Scopus. To access cite count information powered by Scopus, you must have a valid Texas Medical Center Resource Access Account. Need to register for access or forget password? Click here.

Sort By:    Year Published    Cite Count

2024

Collapse All | Expand All

Journal Articles Published in 2024 (n = 2)

Cite Count

PubMed

Reference

0     

Goldman JG, Volpe D, Ellis TD, Hirsch MA, Johnson J, Wood J, et al. Delivering multidisciplinary rehabilitation care in Parkinson's fisease: An international consensus statement. J Parkinsons Dis. 2024;14(1):135-66. PMID: 38277303.

0     

Moon S, Kletzel SL, Santos FH, Devos H, Foster ER, Goldman JG, et al. A patient's guide to memory changes in Parkinson disease. Arch Phys Med Rehabil. 2024;105(3):615-9. PMID: 37256244.

2023

Collapse All | Expand All

Journal Articles Published in 2023 (n = 9)

Cite Count

PubMed

Reference

0     

Henry SK, Talavari D, York MK, Stinson JM, Strutt AM, McCauley SR. Developing a culturally competent neuropsychological assessment battery for Farsi-speaking patients with suspected dementia. Arch Clin Neuropsychol. 2023;38(3):472-84. PMID: 36988547.

0     

McCauley SR, Nguyen T, Nguyen C, Strutt AM, Stinson JM, Windham VA, et al. Developing a culturally competent neuropsychological assessment battery for Vietnamese-speaking patients with suspected dementia. Arch Clin Neuropsychol. 2023;38(3):485-500. PMID: 36988566.

0     

Mishra RK, Park C, Momin AS, Rafaei NE, Kunik M, York MK, et al. Care4AD: A technology-driven platform for care coordination and management: Acceptability study in dementia. Gerontology. 2023;69(2):227-38. PMID: 36096091.

0     

Qi WG, Hong Y, Sun X, Stinson JM, York MK, McCauley S, et al. A neuropsychological battery for the evaluation of dementia among Mandarin-speaking older adults in the United States. Arch Clin Neuropsychol. 2023;38(3):446-58. PMID: 36988501.

0     

Stinson JM, Armendariz V, Hegazy MIR, Strutt AM, McCauley SR, York MK. Developing a culturally competent neuropsychological battery for diagnosis of dementia in Arabic-speaking patients in the United States. Arch Clin Neuropsychol. 2023;38(3):433-45. PMID: 36988467.

0     

Stinson JM, Roman CAF, Combs HL, York MK, Strutt AM, McCauley SR. Geopolitical considerations for working with medically complex patients: A case illustration. Arch Clin Neuropsychol. 2023;38(3):387-94. PMID: 36988412.

0     

Strutt AM, Diaz Santos AL, de Minas Salerno Chiles AL, Furtado M, York MK, Stinson JM, et al. Developing culturally competent foreign language neuropsychological assessments: Portuguese-speaking Brazilians living in the United States. Arch Clin Neuropsychol. 2023;38(3):501-12. PMID: 36988624.

0     

York MK, Alcalay R. Enough vs. More: Neuropsychological testing is more useful than genetic testing in the baseline evaluation of Parkinson disease. Parkinsonism Relat Disord. 2023;111:105403. PMID: 37198082.

0     

York MK, Kim SH, Lee DD, Windham VA, Strutt AM, Stinson JM, et al. Culturally competent approaches for neuropsychological assessment for differential diagnosis of dementia of Korean-speaking patients in the United States. Arch Clin Neuropsychol. 2023;38(3):459-71. PMID: 36988508.

2022

Collapse All | Expand All

Journal Articles Published in 2022 (n = 6)

Cite Count

PubMed

Reference

0     

Cerbone B, Massman PJ, Kulesz PA, Woods SP, York MK. Predictors of rate of cognitive decline in patients with amnestic mild cognitive impairment. Clin Neuropsychol. 2022;36(1):138-64. PMID: 32544371.

0     

Lee M, Mishra RK, Momin A, El-Refaei N, Bagheri AB, York MK, et al. Smart-home concept for remote monitoring of instrumental activities of daily living (IADL) in older adults with cognitive impairment: A proof of concept and feasibility study. Sensors (Basel). 2022;22(18):. PMID: 36146095.

0     

Palmese CA, Wyman-Chick KA, Racine C, Pollak LE, Lin G, Farace E, et al. Assessment of deep brain stimulation candidacy during the COVID-19 pandemic: Lessons learned and future directions for neuropsychologists. Clin Neuropsychol. 2022;36(1):72-84. PMID: 34030595.

0     

Park C, Mishra RK, York MK, Enriquez A, Lindsay A, Barchard G, et al. Tele-medicine based and self-administered interactive exercise program (Tele-Exergame) to improve cognition in older adults with mild cognitive impairment or dementia: A feasibility, acceptability, and proof-of-concept study. Int J Environ Res Public Health. 2022;19(23):. PMID: 36498431.

0     

Rothlind JC, York MK, Luo P, Carlson K, Marks WJ, Jr, et al. Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease. Parkinsonism Relat Disord. 2022;95:23-7. PMID: 34974395.

0     

Zhou H, Park C, Shahbazi M, York MK, Kunik ME, Naik AD, et al. Digital biomarkers of cognitive frailty: The value of detailed gait assessment beyond gait speed. Gerontology. 2022;68(2):224-33. PMID: 33971647.

<2021

Collapse All | Expand All

Journal Articles Published in <2021 (n = 65)

Cite Count

PubMed

Reference

0     

Combs HL, Wyman-Chick KA, Erickson LO, York MK. Development of standardized regression-based formulas to assess meaningful cognitive change in early Parkinson's disease. Arch Clin Neuropsychol. 2021;36(5):734-45. PMID: 33103727.

0     

Faieta JM, Devos H, Vaduvathiriyan P, York MK, Erickson KI, Hirsch MA, et al. Exercise interventions for older adults with Alzheimer's disease: A systematic review and meta-analysis protocol. Syst Rev. 2021;10(1):6. PMID: 33397453.

0     

Mishra R, Park C, York MK, Kunik ME, Wung SF, Naik AD, et al. Decrease in mobility during the COVID-19 pandemic and its association with increase in depression among older adults: A longitudinal remote mobility monitoring using a wearable sensor. Sensors (Basel). 2021;21(9):. PMID: 33946664.

0     

Rothlind JC, York MK, Luo P, Carlson K, Marks WJ, Jr, et al. Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease. Parkinsonism Relat Disord. 2021;95:23-7. PMID: 34974395.

0     

Siddiqui MS, Jimenez-Shahed J, Mari Z, Walter BL, De Jesus S, Panov F, et al. North American survey on impact of the COVID-19 pandemic shutdown on DBS care. Parkinsonism Relat Disord. 2021;92:41-5. PMID: 34688029.

0     

York MK, Farace E, Pollak L, Floden D, Lin G, Wyman-Chick K, et al. The global pandemic has permanently changed the state of practice for pre-DBS neuropsychological evaluations. Parkinsonism Relat Disord. 2021;86:135-8. PMID: 34049812.

0     

Cerbone B, Massman PJ, Woods SP, York MK. Benefit of phonemic cueing on confrontation naming in Alzheimer's disease. Clin Neuropsychol. 2020;34(2):368-83. PMID: 31030619.

0     

Schneider RB, Jimenez-Shahed J, Abraham DS, Thibault DP, Mantri S, Fullard M, et al. Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis. Parkinsonism Relat Disord. 2020;70:96-102. PMID: 31866156.

0     

Weintraub D, Caspell-Garcia C, Simuni T, Cho HR, Coffey CS, Aarsland D, et al. Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease. Ann Clin Transl Neurol. 2020;7(4):449-61. PMID: 32285645.

0     

York MK, Benge JF, Hunter C, Jankovic J. A validation of a self-administered screening test for Parkinson's disease. J Neurol Sci. 2020;418:117116. PMID: 32919368.

0     

 

Combs H, Kim S, York MK. Development and efficacy of a compensatory skill building program: Parkinson's disease cognitive rehabilitation for executive functioning (PD-CORE). Rev Iberoam Neuropsicol. 2019;2(1):43-54.

0     

Philippou E, Polak R, Michunovich A, York M, Faieta JM, Hirsch MA, et al. Food for thought: Basic nutrition recommendations for the mature brain. Arch Phys Med Rehabil. 2019;100(8):1581-3. PMID: 30871790.

3

Lotia M, York MK, Strutt AM, Jankovic J. Leg stereotypy syndrome: Phenomenology and prevalence. J Neurol Neurosurg Psychiatry. 2018;89(7):692-5. PMID: 29332008.

0     

Patel N, Combs H, York M, Phan C, Jimenez-Shahed J. Pseudobulbar affect correlates with mood symptoms in parkinsonian disorders but not amyotrophic lateral sclerosis. J Neuropsychiatry Clin Neurosci. 2018;30(3):214-9. PMID: 29505320.

1

Rossetti MA, Collins RL, York MK. Performance validity in deep brain stimulation candidates. Arch Clin Neuropsychol. 2018;33(4):508-14. PMID: 28961736.

1

Choudhury TK, Harris C, Crist K, Satterwhite TK, York MK. Comparative patient satisfaction and feasibility of a pilot Parkinson's disease enrichment program. J Geriatr Psychiatry Neurol. 2017;30(5):253-60. PMID: 28925334.

3

Krishnan S, York MK, Backus D, Heyn PC. Coping with caregiver burnout when caring for a person with neurodegenerative disease: A guide for caregivers. Arch Phys Med Rehabil. 2017;98(4):805-7. PMID: 28185639.

1

York MK, Moro E. No differences in neuropsychological outcomes between constant current and voltage current subthalamic deep brain stimulation for Parkinson's disease. Ann Transl Med. 2017;5(7):177. PMID: 28480213.

6

Bryant MS, Workman CD, Hou JG, Henson HK, York MK. Acute and Long-Term Effects of Multidirectional Treadmill Training on Gait and Balance in Parkinson Disease. Pm R. 2016;8(12):1151-8. PMID: 27178378.

0     

Heyn PC, Hirsch MA, York MK, Backus D. Physical activity recommendations for the aging brain: a clinician-patient guide. Arch Phys Med Rehabil. 2016;97(6):1045-7. PMID: 27233994.

23

Calleo JS, Amspoker AB, Sarwar AI, Kunik ME, Jankovic J, Marsh L, et al. A pilot study of a cognitive-behavioral treatment for anxiety and depression in patients with Parkinson disease. J Geriatr Psychiatry Neurol. 2015;28(3):210-7. PMID: 26047635.

21

Jacks A, Wainwright DA, Salazar L, Grimes R, York M, Strutt AM, et al. Neurocognitive deficits increase risk of poor retention in care among older adults with newly diagnosed HIV infection. AIDS. 2015;29(13):1711-4. PMID: 26372282.

53

Rothlind JC, York MK, Carlson K, Luo P, Marks WJ, Jr, et al. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: Comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015;86(6):622-9. PMID: 25185211.

9

Hack N, Akbar U, Thompson-Avila A, Fayad SM, Hastings EM, Moro E, et al. Impulsive and compulsive behaviors in Parkinson Study Group (PSG) centers performing deep brain stimulation surgery. J Parkinsons Dis. 2014;4(4):591-8. PMID: 25035311.

3

Fridley J, Adams G, Sun P, York M, Atassi F, Lai E, et al. Effect of subthalamic nucleus or globus pallidus interna stimulation on oculomotor function in patients with Parkinson's disease. Stereotact Funct Neurosurg. 2013;91(2):113-21. PMID: 23343617.

22

Wiszniewski W, Hunter JV, Hanchard NA, Willer JR, Shaw C, Tian Q, et al. TM4SF20 ancestral deletion and susceptibility to a pediatric disorder of early language delay and cerebral white matter hyperintensities. Am J Hum Genet. 2013;93(2):197-210. PMID: 23810381.

28

Armento ME, Stanley MA, Marsh L, Kunik ME, York MK, Bush AL, et al. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: A clinical review. J Parkinsons Dis. 2012;2(2):135-51. PMID: 23939438.

23

Calleo J, Burrows C, Levin H, Marsh L, Lai E, York MK. Cognitive rehabilitation for executive dysfunction in Parkinson's disease: Application and current directions. Parkinsons Dis. 2012;2012:512892. PMID: 22135762.

7

Hall CE, Mirski M, Palesch YY, Diringer MN, Qureshi AI, Robertson CS, et al. Clinical trial design in the neurocritical care unit. Neurocrit Care. 2012;16(1):6-19. PMID: 21792753.

24

Hou JG, Wu LJ, Moore S, Ward C, York M, Atassi F, et al. Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease. Parkinsonism Relat Disord. 2012;18(4):377-81. PMID: 22236581.

18

Marshall DF, Strutt AM, Williams AE, Simpson RK, Jankovic J, York MK. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur J Neurol. 2012;19(12):1525-31. PMID: 22632922.

4

Strutt AM, Ayanegui IG, Scott BM, Mahoney ML, York MK, San Miguel Montes LE. Influence of socio-demographic characteristics on DRS-2 performance in Spanish-speaking older adults. Arch Clin Neuropsychol. 2012;27(5):545-56. PMID: 22693138.

0     

Strutt AM, Palcic J, Wager JG, Titus C, Macadam C, Brown J, et al. Cognition, behavior, and respiratory function in amyotrophic lateral sclerosis. ISRN Neurol. 2012;2012:912123. PMID: 22852095.

37

Strutt AM, Simpson R, Jankovic J, York MK. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur J Neurol. 2012;19(1):121-7. PMID: 21668586.

7

Wijman CA, Smirnakis SM, Vespa P, Szigeti K, Ziai WC, Ning MM, et al. Research and technology in neurocritical care. Neurocrit Care. 2012;16(1):42-54. PMID: 21796494.

60

Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011;17(8):625-8. PMID: 21689962.

9

Jawaid A, Poon M, Strutt AM, Rice LK, McDowell EJ, Salamone AR, et al. Does apolipoprotein E genotype modify the clinical expression of ALS? Eur J Neurol. 2011;18(4):618-24. PMID: 20880000.

10

Strutt AM, Scott BM, Shrestha S, York MK. The Rey 15-item memory test and Spanish-speaking older adults. Clin Neuropsychol. 2011;25(7):1253-65. PMID: 21951176.

45

Williams AE, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord. 2011;17(5):321-7. PMID: 21316292.

6

Hannon PM, Kuo SH, Strutt AM, York MK, Kass JS. Improvement of neurological symptoms and memory and emotional status in a case of seronegative Sneddon syndrome with cyclophosphamide. Clin Neurol Neurosurg. 2010;112(6):544-7. PMID: 20444540.

65

Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, Wheaton M, et al. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler. 2010;11(6):542-8. PMID: 20500116.

57

Jawaid A, Salamone AR, Strutt AM, Murthy SB, Wheaton M, McDowell EJ, et al. ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol. 2010;17(5):733-9. PMID: 20074230.

4

Kalkonde YV, Pinto-Patarroyo GP, Goldman T, Strutt AM, York MK, Kunik ME, et al. Differences between clinical subspecialties in the outpatient evaluation and treatment of dementia in an academic medical center. Dement Geriatr Cogn Disord. 2010;29(1):28-36. PMID: 20110698.

5

Karmonik C, York M, Grossman R, Kakkar E, Patel K, Haykal H, et al. An image analysis pipeline for the semi-automated analysis of clinical fMRI images based on freely available software. Comput Biol Med. 2010;40(3):279-87. PMID: 20074720.

12

Lepow L, Van Sweringen J, Strutt AM, Jawaid A, MacAdam C, Harati Y, et al. Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis. J Clin Exp Neuropsychol. 2010;32(9):913-22. PMID: 20390792.

105

Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, et al. Detecting frontotemporal dysfunction in ALS: Utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler. 2010;11(3):303-11. PMID: 20433413.

0     

York MK, Wilde E, Simpson R, Jankovic J. Acknowledgement of technological limitations while moving literature forward. J Neurol Sci. 2010;292(1-2):120. PMID: 20199780.

14

Dulay MF, Levin HS, York MK, Li X, Mizrahi EM, Goldsmith I, et al. Changes in individual and group spatial and verbal learning characteristics after anterior temporal lobectomy. Epilepsia. 2009;50(6):1385-95. PMID: 18657174.

15

Dulay MF, Levin HS, York MK, Mizrahi EM, Verma A, Goldsmith I, et al. Predictors of individual visual memory decline after unilateral anterior temporal lobe resection. Neurology. 2009;72(21):1837-42. PMID: 19470966.

5

Kalkonde YV, Pinto-Patarroyo GP, Goldman T, Strutt AM, York MK, Kunik ME, et al. Ethnic disparities in the treatment of dementia in veterans. Dement Geriatr Cogn Disord. 2009;28(2):145-52. PMID: 19690417.

2

Shirani P, Salamone AR, Lahijani E, York MK, Schulz PE. Lumbar puncture alleviates chorea in a patient with Huntington's disease and normal pressure hydrocephalus. Behav Neurol. 2009;21(3):193-5. PMID: 20178144.

18

Strutt AM, Lai EC, Jankovic J, Atassi F, Soety EM, Levin HS, et al. Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease. Surg Neurol. 2009;71(5):551-8. PMID: 18514283.

0     

York MK, Strutt AM. A recipe for success: Ingredients to stimulate your mind. J Clin Exp Neuropsychol. 2009;31(7):892-4. PMID: 19096943.

72

York MK, Wilde EA, Simpson R, Jankovic J. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci. 2009;287(1-2):159-71. PMID: 19767016.

5

Dulay MF, Strutt AM, Levin HS, Jankovic J, Lai EC, Grossman RG, et al. Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2008;20(3):357-63. PMID: 18806240.

99

York MK, Dulay M, Macias A, Levin HS, Grossman R, Simpson R, et al. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008;79(7):789-95. PMID: 17965146.

17

York MK, Lai EC, Jankovic J, Macias A, Atassi F, Levin HS, et al. Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: A retrospective analysis. Acta Neurochir (Wien). 2007;149(9):857-66; discussion 866. PMID: 17624489.

22

Dulay MF, York MK, Soety EM, Hamilton WJ, Mizrahi EM, Goldsmith IL, et al. Memory, emotional and vocational impairments before and after anterior temporal lobectomy for complex partial seizures. Epilepsia. 2006;47(11):1922-30. PMID: 17116033.

304

McClure SM, York MK, Montague PR. The neural substrates of reward processing in humans: The modern role of FMRI. Neuroscientist. 2004;10(3):260-8. PMID: 15155064.

22

York MK, Levin HS, Grossman RG, Lai EC, Krauss JK. Clustering and switching in phonemic fluency following pallidotomy for the treatment of Parkinson's disease. J Clin Exp Neuropsychol. 2003;25(1):110-21. PMID: 12607176.

24

York MK, Rettig GM, Grossman RG, Hamilton WJ, Armstrong DD, Levin HS, et al. Seizure control and cognitive outcome after temporal lobectomy: A comparison of classic Ammon's horn sclerosis, atypical mesial temporal sclerosis, and tumoral pathologies. Epilepsia. 2003;44(3):387-98. PMID: 12614395.

22

York MK, Franks JJ, Henry RR, Hamilton WJ. Verbal working memory storage and processing deficits in HIV-1 asymptomatic and symptomatic individuals. Psychol Med. 2001;31(7):1279-91. PMID: 11681554.

0     

York MK, Levin HS, Grossman RG. Pallidotomy and psychological outcomes. J Neurosurg. 2001;94(5):866-8. PMID: 11354429.

38

Rettig GM, York MK, Lai EC, Jankovic J, Krauss JK, Grossman RG, et al. Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000;69(3):326-36. PMID: 10945807.

31

York MK, Levin HS, Grossman RG, Hamilton WJ. Neuropsychological outcome following unilateral pallidotomy. Brain. 1999;122 ( Pt 12):2209-20. PMID: 10581217.

See additional bibliometric measures (requires BCM login).